oral semaglutide cardiovascular outcomes soul trial results 2024 2025 Canadian Perspectives Whiteboard on the In patients with cardiometabolic #HFpEF,

The study participants took 250 mg for the first two days and then were titrated up to 1000 mg

Compounders of GLP-1 medicines should disclose the FDA-registered manufacturer of their API to their customers as a minimal assurance of legitimacy

GLP1/E therapy led to upregulation of pathways involved in autophagy and vesicle-mediated transport, suggesting that this intervention enhances hypothalamic autophagy, a mechanism that may contribute to the metabolic improvement observed in GLP1/E-treated animals

Features of persistent fever and Kawasaki disease (KD) recurrence were observed

Grabrucker, A

Are there good resources explaining how good scientific terms are created